Differential profiles of HDAC1 substrates and associated proteins in breast cancer cells revealed by trapping
Autor: | Kavinda E Herath, Dhanusha A. Nalawansha, Yuchen Zhang, Rafael Andrade, Mary Kay H. Pflum |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Proteomics Histone Deacetylase 1 Triple Negative Breast Neoplasms Biochemistry Article 03 medical and health sciences 0302 clinical medicine Breast cancer Cell Line Tumor Genetics medicine Humans Epigenetics skin and connective tissue diseases Molecular Biology Triple-negative breast cancer Chemistry Cancer Acetylation medicine.disease HDAC1 Histone Deacetylase Inhibitors 030104 developmental biology Cell culture 030220 oncology & carcinogenesis Cancer research Histone deacetylase |
Zdroj: | Mol Omics |
Popis: | Histone deacetylase (HDAC) proteins, which regulate the acetylation state of proteins, are the targets of multiple clinical drugs for cancer treatment. Due to the heterogeneity of tumors, HDAC proteins play different roles in the progression of various cancer types. For example, MDA-MB-468 and MDA-MB-231 cells are both triple negative breast cancer cells but belong to different subtypes that display different response to HDAC inhibitor drugs. To investigate the role of HDAC proteins in breast cancer, the substrate and associated proteins of HDAC1 in MDA-MB-231, MDA-MB-468, and a normal breast epithelial cell line, MCF10A, were analyzed using substrate trapping mutants and proteomics-based mass spectrometry. All three cell lines demonstrated nonoverlapping substrate protein profiles. While both normal MCF10A and cancerous MDA-MB-468 cell lines contained similar HDAC1 associated proteins, including proteins associated with epigenetic and RNA processing mechanisms, the HDAC1 associated protein profile of MDA-MB-231 cells was devoid of expected epigenetic proteins. The variable associated protein profiles of MDA-MB-231 and MDA-MB-468 suggest that HDAC1 plays distinct roles in breast cancer cell biology, which might affect cancer aggressiveness and HDAC inhibitor sensitivity. |
Databáze: | OpenAIRE |
Externí odkaz: |